uniQure N.V. (NASDAQ: QURE) Stock Information | RedChip

uniQure N.V. (NASDAQ: QURE)


$9.03
-0.0850 ( -0.93% ) 576.0K

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Market Data


Open


$9.03

Previous close


$9.11

Volume


576.0K

Market cap


$437.43M

Day range


$8.92 - $9.41

52 week range


$3.73 - $11.35

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 14 Dec 19, 2023
8-k 8K-related 13 Nov 17, 2023
10-q Quarterly Reports 64 Nov 07, 2023
8-k 8K-related 14 Nov 07, 2023
def Proxies and info statements 21 Oct 06, 2023
8-k 8K-related 14 Oct 05, 2023
3 Insider transactions 2 Oct 02, 2023
4 Insider transactions 1 Sep 20, 2023
8-k 8K-related 16 Aug 01, 2023
10-q Quarterly Reports 62 Aug 01, 2023

Latest News